loadpatents
name:-0.025223016738892
name:-0.013489007949829
name:-0.0053620338439941
Baasner; Silke Patent Filings

Baasner; Silke

Patent Applications and Registrations

Patent applications and USPTO patent grants for Baasner; Silke.The latest application filed is for "composition comprising epa and dha for an enhanced efficacy of anticancer agents".

Company Profile
4.12.24
  • Baasner; Silke - Schoneck DE
  • Baasner; Silke - Bad Homburg DE
  • Baasner; Silke - Schoeneck N/A DE
  • Baasner; Silke - Hanau DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Composition comprising EPA and DHA for an enhanced efficacy of anticancer agents
Grant 11,406,614 - Westphal , et al. August 9, 2
2022-08-09
Composition Comprising Epa And Dha For An Enhanced Efficacy Of Anticancer Agents
App 20200306215 - Westphal; Martin ;   et al.
2020-10-01
Long-term efficacy of liver disease treatment with EPA and DHA
App 20200022941 - Westphal; Martin ;   et al.
2020-01-23
Glutamine For Preserving, Improving Or Restoring Kidney Function
App 20190183961 - WESTPHAL; Martin ;   et al.
2019-06-20
Hydroxyalkyl starch for the treatment of hematological neoplasms
Grant 10,272,102 - Westphal , et al.
2019-04-30
Detection of starch levels in biological matrices
Grant 10,202,634 - Baasner , et al. Feb
2019-02-12
Use Of A Mixture Of Modified Glucose Polymers For Reducing Tumor Metastasis
App 20180021367 - Sundermann; Bernd ;   et al.
2018-01-25
Detection Of Starch Levels In Biological Matrices
App 20170175165 - Baasner; Silke ;   et al.
2017-06-22
Polysaccharide For Use In Preventing Metastasis Formation And/or Relapse
App 20160175340 - Sundermann; Bernd ;   et al.
2016-06-23
Hydroxyalkyl Starch For The Treatment Of Hematological Neoplasms
App 20160175341 - Westphal; Martin ;   et al.
2016-06-23
Hydroxyalkyl Starch For The Treatment Of Cancers By Reduction Of Tumor Growth Rates
App 20160082036 - Westphal; Martin ;   et al.
2016-03-24
Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors
Grant 8,541,462 - Schuster , et al. September 24, 2
2013-09-24
Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates
App 20130197211 - Westphal; Martin ;   et al.
2013-08-01
Hydroxyalkyl starch for the treatment of head and neck cancers by reduction of tumor growth rates
App 20130197212 - Westphal; Martin ;   et al.
2013-08-01
Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates
App 20130196949 - Westphal; Martin ;   et al.
2013-08-01
Novel Tetrahydrocarbazole Derivatives As Ligands Of G-protein Coupled Receptors
App 20120122763 - SCHUSTER; Tilmann ;   et al.
2012-05-17
Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors
Grant 8,148,546 - Schuster , et al. April 3, 2
2012-04-03
Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs)
Grant 8,067,456 - Paulini , et al. November 29, 2
2011-11-29
Use of Disorazoles and Their Derivatives for the Treatment of Benign and Malignant Oncoses
App 20090311264 - Irschik; Herbert ;   et al.
2009-12-17
Novel Tetrahydrocarbazole Derivatives As Ligands Of G-protein Coupled Receptors
App 20090170783 - Schuster; Tilmann ;   et al.
2009-07-02
Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs)
App 20080280965 - Paulini; Klaus ;   et al.
2008-11-13
Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs)
Grant 7,375,127 - Paulini , et al. May 20, 2
2008-05-20
N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation
Grant 7,211,588 - Gerlach , et al. May 1, 2
2007-05-01
Indole derivatives having an apoptosis-inducing effect
Grant 7,205,299 - Gerlach , et al. April 17, 2
2007-04-17
Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs)
App 20060014818 - Paulini; Klaus ;   et al.
2006-01-19
Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals
App 20050267303 - Weinberger, Heinz ;   et al.
2005-12-01
N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation
App 20050020636 - Gerlach, Matthias ;   et al.
2005-01-27
New anthracene derivatives and their use as pharmaceutical preparations
App 20040110756 - Emig, Peter ;   et al.
2004-06-10
Use of the disorazoles and their derivatives for the treatment of benign and malignant oncoses
App 20040106662 - Irschik, Herbert ;   et al.
2004-06-03
Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
App 20040097734 - Gerlach, Matthias ;   et al.
2004-05-20
Heteroaryl derivatives and their use as medicaments
Grant 6,706,722 - Emig , et al. March 16, 2
2004-03-16
Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals
App 20040039197 - Weinberger, Heinz ;   et al.
2004-02-26
Novel heteroaryl derivatives and their use as medicaments
App 20020132821 - Emig, Peter ;   et al.
2002-09-19
2-acyl indole derivatives and their use as antitumor agents
App 20020091124 - Beckers, Thomas ;   et al.
2002-07-11
Tumorigenic cell lines altered by genetic engineering and their use for the testing of antitumor drugs
Grant 5,837,462 - Beckers , et al. November 17, 1
1998-11-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed